What is Dor Lotan's specialty?

Dor Lotan (NPI 1265009047) is a Medicare-billing provider whose primary specialty is Advanced Heart Failure and Transplant Cardiology in New York, NY.

Where does Dor Lotan practice?

Dor Lotan practices in New York, NY, based on the location reported in the CMS Medicare provider datasets for NPI 1265009047.

How much does Medicare pay Dor Lotan?

Dor Lotan (NPI 1265009047) received approximately $52K in total Medicare Part B payments, serving 175 beneficiaries, per the CMS Medicare Physician & Other Practitioners dataset.

PROVIDER PROFILE · NPI 1265009047

Dor LotanMD

Advanced Heart Failure and Transplant CardiologyNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

300

Unique beneficiaries

—

Total services

531

Distinct HCPCS

Medicare payment

$48K

Peer benchmark

Total Medicare services vs. 77 Advanced Heart Failure and Transplant Cardiology providers in NY — below median (cohort median 680).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$393K

Distinct drugs

Brand share

75.0%

Top prescribed drugs

Sacubitril/Valsartan24 claims

Rilonacept18 claims

Torsemide14 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

85.3

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$49K

Payment records

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$41K

Travel and Lodging$5K

Food and Beverage$4K

Top paying entities

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$41K

Travel and Lodging$5K

Food and Beverage$4K

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 310045

Hospital

CCN 330101

Hospital

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history